August 24, 2016 9:41 AM ET

Biotechnology

Company Overview of NOXXON Pharma AG

Executive Profile

Lawrence E. Posner M.D.

Member of the Supervisory Board, NOXXON Pharma AG
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Lawrence E. Posner, M.D., also known as Larry, serves as a Consultant to Polyphenon Pharma. He was a General Partner at Vedanta Capital. He began his career in the pharmaceutical industry in 1983 at the American Cyanamid Company's Lederle Laboratories. He served the positions of Senior Vice President and Head of U.S. Research and Development of Yamanouchi Pharmaceuticals U.S.A, Inc.; Senior Vice President and Worldwide Head of Regulatory Affairs, Ethical Pharmaceuticals ...

Corporate Headquarters

Max-Dohrn-Str. 8-10
Berlin, Berlin 10589

Germany

Phone: 49 30 72 62 47 0
Fax: 49 30 72 62 47 225

Board Members Memberships

There is no Board Members Memberships data available.

Education

Master's Degree 2006
University of Connecticut
MD 1974
Case Western Reserve University
Unknown/Other Education
Brandeis University
BA 1970
Brandeis University
Unknown/Other Education
NYU Elaine A. and Kenneth G. Langone Medical Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NOXXON Pharma AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.